Clinical Trial Update: A Longitudinal Study to Evaluate an Extracellular Matrix (MatriStem®) for the Treatment of Diabetic Foot Ulcers [NA]

View source ↗

Summary

This document reports a completed longitudinal clinical trial evaluating MatriStem extracellular matrix for the treatment of neuropathic diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Diabetic Foot Ulcer

Drugs mentioned

• MatriStem (extracellular matrix)

Snippet

Sponsor: Calvary Hospital, Bronx, NY | Conditions: Neuropathic Diabetic Foot Ulcer | NA | Status: COMPLETED